Physician profile
Dana Pfaff
NPI 1235198227
$741.03
in general payments reported to CMS, 2019-2025
18 companies · $21.74 in 2025
The $21.74 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $260 · 2021: $43.47 · 2022: $11.66 · 2025: $21.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $118.31 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $70.88 | 2019-2020 | |
| Abbvie INC. | $70.69 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $63.89 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.30 | 2019 | |
| Boston Scientific Corporation | $50.96 | 2019 | |
| Coloplast Corp | $50.30 | 2019-2020 | |
| 180 Medical, INC. | $40.32 | 2019-2020 | |
| Rochester Medical Corporation | $38.08 | 2020 | |
| Hollister Incorporated | $35.20 | 2019-2020 | |
| Myovant Sciences INC. | $25.95 | 2021 | |
| Blue Earth Diagnostics | $24.30 | 2020 | |
| Stryker Corporation | $21.74 | 2025 | Protrieve Sheath |
| Myriad Genetic Laboratories, INC. | $17.52 | 2021 | |
| Gilead Sciences, INC. | $15.97 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $14.48 | 2020 | |
| Photocure INC | $12.48 | 2020 | |
| Urogen Pharma, INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Pfaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.